GGrantIndex
← Leaderboards

Kate E Keller

Oregon Health & Science University

$7,804,948
Attributed
$8,297,195
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,921,195 · 6

By mechanism

R01$6,613,603 · 2
T32$1,243,132 · 1
P30$646,735 · 2
R21$417,725 · 1

Top collaborators

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularResponseGlaucomaPhysiologic Intraocular PressurePressureExtracellular MatrixResistanceAqueous HumorBlindnessTrabecular Meshwork StructureCellsMatrix MetalloproteinasesAffectPerfusionTissuesAnteriorRisk FactorsCell PhysiologyConfocal MicroscopyPathway InteractionsRegulationAqueousStructureComplex

Grant awards (31)

Ophthalmology Core Facility$624,000
P30 · FY2025 · EY · contact PI
Extracellular Matrix and Outflow Resistance$426,611
R01 · FY2025 · EY · contact PI
Thrombospondin-1 in normal and glaucomatous trabecular meshwork$391,908
R01 · FY2025 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$177,523
T32 · FY2025 · EY · contact PI
Administrative Core$22,735
P30 · FY2025 · EY · contact PI
Extracellular Matrix and Outflow Resistance$426,611
R01 · FY2024 · EY · contact PI
Thrombospondin-1 in normal and glaucomatous trabecular meshwork$391,908
R01 · FY2024 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$163,817
T32 · FY2024 · EY · contact PI
Extracellular Matrix and Outflow Resistance$426,611
R01 · FY2023 · EY · contact PI
Thrombospondin-1 in normal and glaucomatous trabecular meshwork$393,610
R01 · FY2023 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$175,079
T32 · FY2023 · EY · contact PI
Extracellular Matrix and Outflow Resistance$413,812
R01 · FY2022 · EY · contact PI
Thrombospondin-1 in normal and glaucomatous trabecular meshwork$409,295
R01 · FY2022 · EY · contact PI
In vivo trabecular meshwork gene expression response to elevated IOP$186,725
R21 · FY2022 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$156,079
T32 · FY2022 · EY · contact PI
Extracellular Matrix and Outflow Resistance$422,761
R01 · FY2021 · EY · contact PI
In vivo trabecular meshwork gene expression response to elevated IOP$231,000
R21 · FY2021 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$159,106
T32 · FY2021 · EY · contact PI
AI training module for Vision Science$86,400
T32 · FY2021 · EY · contact PI
Extracellular matrix and outflow resistance$346,500
R01 · FY2020 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$172,238
T32 · FY2020 · EY · contact PI
Extracellular matrix and outflow resistance$346,500
R01 · FY2019 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$152,890
T32 · FY2019 · EY
Extracellular matrix and outflow resistance$346,500
R01 · FY2018 · EY · contact PI
Extracellular matrix and outflow resistance$346,500
R01 · FY2017 · EY · contact PI
Extracellular matrix and outflow resistance$346,500
R01 · FY2016 · EY · contact PI
Extracellular Matrix and Outflow Resistance$217,324
R01 · FY2014 · EY · contact PI
Extracellular Matrix and Outflow Resistance$210,672
R01 · FY2013 · EY · contact PI
Extracellular Matrix and Outflow Resistance$221,760
R01 · FY2012 · EY · contact PI
Extracellular Matrix and Outflow Resistance$258,720
R01 · FY2011 · EY · contact PI
Extracellular Matrix and Outflow Resistance$269,500
R01 · FY2010 · EY · contact PI